Amarin Corporation plc

Filed a patent for "compositions and methods for treating and/or preventing cardiovascular disease" on Thu, July 4, 2024

Filed a patent for "methods of reducing risks of cardiovascular events in subjects with low baseline epa:aa ratio" on Thu, November 10, 2022

Filed a patent for "pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin" on Thu, January 18, 2024

Filed a patent for "lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment" on Thu, January 26, 2023

Filed a patent for "pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same" on Thu, January 25, 2024

Filed a patent for "co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereof" on Thu, October 5, 2023

Filed a patent for "methods of treating hypertriglyceridemia" on Thu, January 25, 2024

Filed a patent for "methods of reducing the risk of a cardiovascular event in a subject on statin therapy" on Thu, October 26, 2023

Filed a patent for "stable pharmaceutical composition and methods of using same" on Thu, May 9, 2024

Filed a patent for "lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment" on Thu, May 23, 2024

Filed a patent for "compositions comprising epa and methods of using the same for treating and/or preventing endothelial dysfunction in a subject" on Thu, May 30, 2024

Filed a patent for "methods of reducing the risk of cardiovascular events in a subject" on Thu, April 6, 2023

Filed a patent for "methods of reducing the risk of heart failure" on Thu, November 3, 2022

Filed a patent for "methods of treating mixed dyslipidemia" on Thu, August 4, 2022

Filed a patent for "methods of treating hypertriglyceridemia" on Thu, October 13, 2022

Filed a patent for "methods of treating hypertriglyceridemia" on Fri, July 1, 2022

Filed a patent for "co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereof" on Mon, July 11, 2022

Filed a patent for "compositions and methods for lowering triglycerides" on Thu, July 6, 2023

Filed a patent for "compositions and methods for lowering triglycerides in a subject with reduced kidney function and diabetes mellitus" on Thu, August 10, 2023